Related Experiment Video
Updated: Jun 16, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Clinical Significance of NUDT1 (MTH1) Across Cancer Types
Radosław Misiak1, Karol Białkowski2, Ewelina Dondajewska1
1Department of Medical Biotechnology, Poznan University of Medical Sciences (PUMS), 61-701 Poznan, Poland.
Abstract:
MTH1 (MutT Homolog 1) protein is one of the enzymes that protect cells from mutagenetic actions of reactive oxygen species. It sanitizes the pool of free nucleotides, making sure that oxidized dNTPs are not incorporated into the DNA. Any misfunction of it would lead to mutations. As such, it has attracted interest of cancer researchers, and multiple studies have been conducted over the years to determine its role in tumor cells. It has been found that MTH1 is not downregulated in most tumor tissues but, to the contrary, often overexpressed. This suggests that MTH1 is used by cancer as an adaptation to increased oxidative stress caused by metabolic reprogramming to support excessive proliferation. Based on this premise, many recent studies have evaluated MTH1 as either prognostic factor, general biomarker or therapeutic target in cancer. Here, we summarize all available research on MTH1 mRNA, protein and its enzymatic activity in clinical samples across various cancer types, identifying a subset of cancers where MTH1 plays an important role. This is particularly evident in cancers characterized by high metabolic activity and oxygen-rich environments, such as hepatocellular carcinoma, renal cell carcinoma, or non-small cell lung adenocarcinoma.
Insights
MutT Homolog 1 (MTH1) enzyme protects DNA from oxidative damage. MTH1 is often overexpressed in cancers, suggesting it supports tumor growth under high oxidative stress and may be a therapeutic target.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- MutT Homolog 1 (MTH1) is an enzyme crucial for sanitizing nucleotide pools, preventing incorporation of oxidized dNTPs into DNA.
- MTH1 dysfunction can lead to mutations, making it a key player in cellular protection against reactive oxygen species.
- MTH1 is frequently overexpressed in tumor tissues, unlike its downregulation in normal cells.
Purpose of the Study:
- To review and summarize existing research on MTH1 mRNA, protein, and enzymatic activity in clinical cancer samples.
- To identify specific cancer types where MTH1 plays a significant role.
- To evaluate MTH1 as a prognostic factor, biomarker, and potential therapeutic target in oncology.
Main Methods:
- Comprehensive literature review of studies investigating MTH1.
- Analysis of MTH1 expression (mRNA, protein) and enzymatic activity in diverse cancer types.
- Correlation of MTH1 levels with clinical data and cancer characteristics.
Main Results:
- MTH1 is overexpressed in numerous cancer types, indicating its utilization by cancer cells to cope with oxidative stress.
- MTH1 overexpression is particularly prominent in cancers with high metabolic activity and oxygen-rich environments.
- Specific examples include hepatocellular carcinoma, renal cell carcinoma, and non-small cell lung adenocarcinoma.
Conclusions:
- MTH1 is an important factor in cancer adaptation to metabolic reprogramming and oxidative stress.
- MTH1's role is significant in specific high-metabolic cancers, highlighting its potential as a therapeutic target.
- Further research into MTH1 inhibition could offer novel cancer treatment strategies.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
The Nucleolus
Non-Canonical Wnt Signaling Pathways
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...

